🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

(1/7) Most known #carcinogens were identified pre-1980. The causes behind ~ half of #preventable #cancer cases remain unknown. In a recent paper george davey smith & Paul Brennan discuss the remaining undiscovered risk factors: link.springer.com/article/10.100… Few take-home notes 🧵👇:

Thread on why ubiquitous exposures may underlie a large proportion of cancer cases of unknown cause

I just discovered who visited my Twitter profile! funxgames.me/who-visits-you… ⠀

My Twitter Interaction Circle ➡️ funxgames.me/twittercircle

1/n I first read this sitting on a stool in the HK Lewis medical bookshop on Gower Street soon after it came out; the book was outside my budget & the rest not so interesting. It felt like the 19th century in Lewis' anachronistic shop, there were hardly any customers /cont

Combining cancer genomics, epidemiology and biology to understand prevention..... 📢Registrations now open for the #BarcelonaBiomed Conference "#Cancer Promotion: Understanding Cancer Promotion to Inform Prevention!". 3rd-5th June ➡️bit.ly/48P6qsO

The Mutographs biorepository: A unique genomic resource to study cancer around the world cell.com/cell-genomics/… IARC Wellcome Sanger Institute Cancer Grand Challenges Cell Genomics

A study finds that proteomics-based risk model for lung cancer can predict incident #LungCancer and outperformed both a smoking-based risk prediction (PLCOm2012) and a commercially available autoantibody biomarker test for #LungCancerScreening. Read more: oxford.ly/3uczdIU

Today, we launch the largest ever philanthropic campaign by a UK charity. More Research, Less Cancer aims to raise £400m to contribute to the work at The Crick, help fund Cancer Grand Challenges, support scientists at all stages of their career, and enable more innovations that lead to

In randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to cancer-specific mortality for some cancer types but is not suitable for others, finds meta-analysis of 41 RCTs. ja.ma/49vbh22 #AACR24

It's been a great few days at #AACR24 in San Diego. I had the chance to present our latest findings from the #MUTOGRAPHS head and neck cancer project. Missed the talk? You can catch it on the AACR online platform, or stay tuned for the preprint coming soon!

OUT IN nature: Geographic variation of mutagenic exposures in kidney cancer genomes! The power of Mutographs Cancer Grand Challenges demonstrated on this landmark paper! Congrats Sergey Senkin, Sarah Moody, Mike Stratton Wellcome Sanger Institute, Paul Brennan IARC et al! nature.com/articles/s4158…

And thanks to the brilliant Cancer Grand Challenges team at CRUK for their total support since Mutographs started, as well as wonderful scientific journey with Wellcome Sanger Institute and UC San Diego colleagues (esp Sarah Moody), partners in the 11 countries, and all the great team IARC.

I am thrilled that our paper on kidney cancer is now out in nature!!! nature.com/articles/s4158…

1/ Now out at Journal of Clinical Oncology! Plasma KIM-1 (pKIM-1) helps predict benign vs malignant renal masses and is prognostic for clinical outcomes. ascopubs.org/doi/10.1200/JC…

Fantastic start to the conference organized by Cancer Grand Challenges PROMINENT teal leaders Nuria Lopez-Bigas (IRB Barcelona) Paul Brennan (IARC) & Allan Balmain (UCSF Helen Diller Family Comprehensive Cancer Ctr) on "Cancer Promotion to inform prevention". What a beautiful venue too 🏫! Sant Pau - Campus Salut Barcelona irbbarcelona.org/en/events/canc…

Sir Richard Peto and late acting determinants of cancer… last day of this wonderful meeting in Barcelona with Nuria Lopez-Bigas and Allan Balmain on how understanding cancer promotion can inform prevention…⁦IARC⁩

🗣️The 41st #BarcelonaBioMed Conference reveals new avenues for #cancer prevention. ➕150 international scientists have discussed the factors that contribute to the risk of getting #cancer & their implication in the prevention of the disease. 🤝Fundación BBVA Read more here

Fascinating insights into international variations in #cancerincidence from analysis of tumour #mutation patterns. Mutational mapmakers chart course to #cancerprevention IARC Michelle Mitchell Paul Brennan @NCIprevention CDC Cancer science.org/content/articl…

Great discussion about early onset cancers with Kimmie Ng, MD, MPH and Science and Innovation at Cancer Research UK Cancer Grand Challenges National Cancer Institute funded research: what is the underlying cause ? Obesity, western diet, microbiome, antibiotic use ?